Concepedia

Publication | Open Access

A Phase II Trial of Prexasertib (LY2606368) in Patients With Extensive-Stage Small-Cell Lung Cancer

DOIFull Paper Access

36

Citations

23

References

2021

Year

Lauren A. Byers, Alejandro Navarro, Eric Schaefer, Melissa L. Johnson, Mustafa Özgüroğlu, Ji‐Youn Han, Igor Bondarenko, İrfan Çiçin, Konstantin H. Dragnev, Adam Abel,
Clinical Lung Cancer

Abstract

Prexasertib did not demonstrate activity to warrant future development as monotherapy in ED-SCLC.

References

YearCitations

Page 1